EA
NXTM

Emerald Acquisition’s NxStage Medical Inc. NXTM Stock Holding History

Emerald Acquisition’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$376K Buy
+15,054
New +$351K ﹤0.01% 2539

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Emerald Acquisition's NXTM Position: Q3 2016 in Review

Emerald Acquisition opened a new position in NxStage Medical Inc. (NXTM) in Q3 2016: 15,054 shares worth $376K. The stake represents ﹤0.01% of the portfolio and ranks #2539 among its holdings.

156 funds tracked by Wall St. Rank hold NXTM as of Q3 2016.

  • Emerald Acquisition held 15,054 shares of NxStage Medical Inc. worth $376K as of Q3 2016.
  • NxStage Medical Inc. was a new Emerald Acquisition position in Q3 2016.
  • NxStage Medical Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2539 holding.
  • 156 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.